Join an expert-led User Group Meeting designed for leaders in Clinical, R&D, and Digital Innovation to explore how Agentic AI is shaping the future of clinical trials. This full-day event brings together customers, industry experts, and peers for thought leadership, product innovation, and networking opportunities.

What Awaits You:

• Visionary Keynotes – Discover how Agentic AI is transforming clinical trials.
• Product Showcase – Get an exclusive look at Maxis AI’s roadmap and innovations.
• Customer Spotlights – Hear real-world success stories from industry leaders.
• Interactive Workshops – Experience hands-on sessions with Agentic AI tools.
• Peer Networking – Connect with innovators and decision-makers across the industry.

Pre-Event Gathering:
📅 Oct 27, 2025 | 6:00 PM – 8:00 PM
🍽️ Welcome Dinner (optional) – The Westin Princeton at Forrestal Village

Agenda Highlights (Oct 28, 2025):

8:00 AM – 9:00 AM – Registration, Coffee & Breakfast

9:10 AM – Keynote
Dr. Anastasia Christianson, Managing Principal, EPAM Systems

9:55 AM – Maxis AI: This Year and Forward
Varsha Kishore & Moulik Shah, Maxis AI

10:15 AM – Industry Presentation
Chandi Kodthiwada, VP of Product, Komodo Health

10:45 AM – Maxis AI Platform Showcase
Varsha Kishore, Maxis AI

11:15 AM – Panel Discussion
Topic: Agents of Change: The Rise and Inspiration of Agentic AI in Clinical Development

12:30 PM – Lunch & Networking

1:30 PM – Patient Engagement Expert Session
T.J. Sharpe, Sharpe Patient Insights

2:15 PM – Agentic AI Use Cases Showcase
Agentic AI Team, Maxis AI

3:15 PM – Break

3:30 PM – Session
Kuldeep Kataria, Maxis AI

4:00 PM – Session
Rajesh Hagalwadi, Maxis AI

4:30 PM – Open Discussion

5:00 PM – Closing Remarks
Nicole Powell, Maxis AI

5:00 PM – Networking Dinner
Westin Princeton at Forrestal Village (Village Square)

Location:

The Westin Princeton at Forrestal Village
201 Village Boulevard, Princeton, NJ 08540
(Room: Nassau)

“Leading the charge with Agentic AI, we are not following trends – we are setting the benchmark for the future of clinical trials.”